Hepatitis B: all 1,662 studies

Page 10 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.

• Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.CompletedNCT03241641Phase 4
• Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus TenofovirStatus unknownNCT03236610Phase 3
• Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus AdefovirStatus unknownNCT03236584Phase 3
• Radiomics for Diagnosing Liver Diseases and Evaluating ProgressionStatus unknownNCT03221049
• Immunologic Response of Hepatitis B VaccineStatus unknownNCT03219203Phase 4
• Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, SenegalCompletedNCT03215732
• The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionStatus unknownNCT03214302Not applicable
• HBV Vaccination in HIV-infected AdultsStatus unknownNCT03212911Phase 4
• The Changes of Cytokines During Antiviral TherapyStatus unknownNCT03210506Not applicable
• The Changes of Treg Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210493Not applicable
• The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210467
• The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal TimeStatus unknownNCT03209908
• The Changes of CD8+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209037Phase 4
• The Changes of CD4+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209011Phase 4
• The Changes of Natural Killer Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03208998Phase 4
• A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy AdultsCompletedNCT03208101Phase 1
• Impact of Hepatitis B Vaccination on HBs AntigenemiaCompletedNCT03193775Not applicable
• Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa TherapyCompletedNCT03181113
• The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03180333Phase 1
• The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03173599Phase 1
• Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B PatientsTerminatedNCT03164889Not applicable
• Optimizing HBV Management During Anti-CD20 AntibodiesCompletedNCT03155984
• Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis PatientsCompletedNCT03149874Not applicable
• A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B SubjectsWithdrawnNCT03125213Phase 2
• To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.Status unknownNCT03123653Not applicable
• Clinical Performance Evaluation of DxN HBV AssayTerminatedNCT03123159
• TAF for HIV-HBV With Renal DysfunctionCompletedNCT03115736Phase 2
• "Treatment of Active HBV With γδT Cells" Clinical Trial ProtocolStatus unknownNCT03113058Early Phase 1
• Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis BCompletedNCT03109730Phase 1/2
• Pilot Study of HIV and Hepatitis B and C Screening in SurgeryCompletedNCT03088995
• A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)CompletedNCT03086564Phase 1/2
• The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCCStatus unknownNCT03084250Phase 4
• Immunity to Hepatitis B VaccineCompletedNCT03083158Phase 4
• Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)Status unknownNCT03062813Phase 4
• Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With VedolizumabCompletedNCT03056924
• Off-therapy Response After Stopping Entecavir or TenofovirStatus unknownNCT03042481
• Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy VolunteersTerminatedNCT03032536Phase 1
• Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth OutcomeStatus unknownNCT03027258Not applicable
• Study of Hepalatide(L47) at Phase Ib in Healthy VolunteersCompletedNCT03023787Phase 1
• The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis BStatus unknownNCT03018821Not applicable
• Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B PatientsStatus unknownNCT03013556Phase 4
• Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B VirusCompletedNCT02995005Phase 1/2
• Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus CarriersStatus unknownNCT02991638Phase 3
• To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis BStatus unknownNCT02982837Phase 4
• REALM China Extension StudyStatus unknownNCT02974829
• Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor DetectionStatus unknownNCT02973646Phase 4
• Efficacy and Safety of DA-2802 in Chronic Hepatitis B PatientsCompletedNCT02967939Phase 3
• The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis BStatus unknownNCT02965859Phase 2
• Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in FranceStatus unknownNCT02959684
• TAF Switch Study in Hepatitis B MonoinfectionStatus unknownNCT02957994Phase 4
• Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative ConcentrationStatus unknownNCT02953600Not applicable
• Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02945956Phase 4
• Tenofovir As Prevention Of Hepatitis b Mother-to-child TransmissionStatus unknownNCT02937779Phase 4
• Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or CuredCompletedNCT02909023
• HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection PatientsStatus unknownNCT02908763Phase 4
• A Study in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT02908191Phase 1
• A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High RiskStatus unknownNCT02901418
• Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B VirusStatus unknownNCT02899130Not applicable
• Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in ChinaCompletedNCT02898922Phase 4
• A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAsStatus unknownNCT02894918Phase 4
• The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAgStatus unknownNCT02893124Phase 4
• French HIV-HBV CohortStatus unknownNCT02889094
• Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB InfectionStatus unknownNCT02886182
• Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid TumorsCompletedNCT02877589
• A Long Term Follow-up Study of Patients From the REP 301 ProtocolCompletedNCT02876419
• Pharmacokinetics of Two Formulations of EntecavirCompletedNCT02850848Phase 4
• Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis PatientsActive, not recruitingNCT02849132Phase 4
• The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).Active, not recruitingNCT02845401Not applicable
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02838810Phase 4
• EFFORT Further Extension StudyStatus unknownNCT02826070Phase 4
• A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) InfectionTerminatedNCT02826018Phase 1
• Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) AdultsStatus unknownNCT02822547Phase 4
• Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
• DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected InfantsCompletedNCT02817451Phase 3
• Liver Injury by Statins in Patients With History of Hepatitis B Virus InfectionStatus unknownNCT02808299
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 TabletStatus unknownNCT02805738Phase 3
• Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?Status unknownNCT02799316Not applicable
• HBV Virions Bound ProteinsCompletedNCT02798549Not applicable
• Study of the Long Term Efficacy of Recombinant Hepatitis B Vaccine in Nile Delta of EgyptStatus unknownNCT02797782
• Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive PatientsStatus unknownNCT02793791Not applicable
• Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside AnaloguesCompletedNCT02792088Phase 3
• Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue TherapyCompletedNCT02791386
• Hepatocellular Carcinoma in HIV-infected PatientsCompletedNCT02785835
• Dynamic Liver Tests in Liver DiseaseCompletedNCT02782247
• Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777814Phase 2
• Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777801Phase 2
• Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis BStatus unknownNCT02774837Phase 4
• Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort StudyCompletedNCT02766933
• Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the NeonatesStatus unknownNCT02764671Phase 4
• Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian AmericansCompletedNCT02760537Not applicable
• Counseling and Reminders for Regular HIV and STIs ScreeningCompletedNCT02752152Not applicable
• A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBVCompletedNCT02751996Phase 2
• Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP)CompletedNCT02749864
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02745704Phase 4
• Off Treatment Durability in Chronic Hepatitis B With Good Immune ControlCompletedNCT02738554Not applicable
• Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell CountsCompletedNCT02732054Phase 4
• Study of Antiretroviral Therapy to Prevent HBV Intrauterine InfectionStatus unknownNCT02719808
• Hepatitis B Vaccination in HIV-infected AdultsCompletedNCT02713620Phase 4
• Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.CompletedNCT02697474Phase 3
• A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B VaccineCompletedNCT02693652Phase 1/2

← Hepatitis B overview